Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 880-889

  Vultaggio, Alessandra ^a   Nencini, Francesca ^a   Fitch, Paul M ^a   Filì, Lucia ^a   Maggi, Laura ^a   Fanti, Paola ^a   DeVries, Annick ^b   Beccastrini, Enrico ^a   Palandri, Francesca ^a   Manuelli, Cinzia ^a   Bani, Daniele ^a   Giudizi, Maria Grazia ^a   Guarna, Antonio ^a   Annunziato, Francesco ^a   Romagnani, Sergio ^a   Maggi, Enrico ^a   Howie, Sarah E M ^b   Parronchi, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

9 BENZYL 2 BUTOXY 8 HYDROXYADENINE; ADENINE DERIVATIVE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 6; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ADENINE; CHEMOKINE; CYTOKINE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; TLR7 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; TH0 CELL; TH1 CELL; TH2 CELL; ACUTE DISEASE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL LINE; IMMUNOLOGY; LUNG DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ACUTE DISEASE; ADENINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; LUNG DISEASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; TH2 CELLS; TOLL-LIKE RECEPTOR 7; UP-REGULATION;

EID: 60549100776     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.880     Document Type: Article

References (38)

1. Pelaia, G., A. Vatrella, L. Gallelli, T. Renda, M. Cazzola, R. Maselli, and S. A. Marsico. 2006. Respiratory infections and asthma. Resp. Med. 100: 775-784.
2. Johnstone, S. L. 2007. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc. Am. Thorac. Soc. 4: 267-270.
3. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
4. Liotta, F., F. Frosali, V. Querci, L. Maggi, B. Mazzinghi, R. Angeli, E. Ronconi, V. Santarlasci, T. Biagioli, C. Ballerini, et al. 2008. Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction. J. Allergy Clin. Immunol. 121: 1000-1005.
5. Parronchi, P., E. Maggi, and S. Romagnani. 1999. Redirecting TH2 responses in allergy. Curr. Top. Microbiol. Immunol. 238: 27-56.
6. Simons, F. E., Y. Shikishima, G. Van Nest, J. J. Eiden, and K. T. HayGlass. 2004. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy Clin. Immunol. 113: 1144-1151.
7. Tulic, M. K., P. O. Fiset, P. Christodoulopoulos, P. Vaillancourt, M. Desrosiers, F. Lavigne, J. Eiden, and Q. Hamid. 2004. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J. Allergy Clin. Immunol. 113: 235-241.
8. Moisan, J., P. Camateros, T. Thuraisingam, D. Marion, H. Koohsari, P. Martin, M. L. Boghdady, A. Ding, M. Gaestel, M. C. Guiot, et al. 2006. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am. J. Physiol. 290: L987-L995.
9. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
10. H2 lymphocytes into IFN-γ-producing cells. J. Allergy Clin. Immunol. 111: 380-388.
11. Filì, L., S. Ferri, F. Guarna, S. Sampognaro, C. Manuelli, F. Liotta, L. Cosmi, A. Matucci, A. Vultaggio, F. Annunziato, et al. 2006. Redirection of allergenspecific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. J. Allergy Clin. Immunol. 118: 511-517.
12. Hirota, K., K. Kazaoka, I. Niimoto, H. Kumihara, H. Sajiki, Y. Isobe, H. Takaku, M. Tobe, H. Ogita, T. Ogino, et al. 2002. Discovery of 8-hydroxyadenines as a novel type of interferon inducer. J. Med. Chem. 45: 5419-5422.
13. Jurk, M. F. Heil, J. Vollmer, C. Schetter, A. M. Krieg, H. Wagner, G. Lipford, and S. Bauer. 2002. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3: 196-200.
14. + regulatory cells. J. Immunol. 179: 7050-7058.
15. Van Rijt, L. S., H. Kuipers, N. Vos, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2004. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 288: 111-121.
16. Boonstra, A., C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, Y. J. Liu, and A. O'Garra. 2003. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 197: 101-109.
17. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428.
18. Till, S. J., J. N. Francis, K. Nouri-Aria, and S. R. Durham. 2004. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113: 1025-1034.
19. + T cells into TH1 effectors. J. Immunol. 163: 5946-5953.
20. A. Kurimoto, T. Ogino, S. Ichii, Y. Isobe, M. Tobe, H. Ogita, H. Takaku, H. Sajiki, K. Hirota, and H. Kawakami. 2004. Synthesis and structure-activity relationships of 2-amino-8-hydroxyadenines as orally active interferon inducing agents. Bioorg. Med. Chem. 12: 1091-1099.
21. Lee, J., C. C. Wu, K. J. Lee, T. H. Chuang, K. Katakura, Y. T. Liu, M. Chan, R. Tawatao, M. Chung, C. Shen, et al. 2006. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 103: 1828-1833.
22. Asselin-Paturel, C., G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri. 2005. Type I interferon dependence of plasmocytoid dendritic cell activation and migration. J. Exp. Med. 201: 1157-1167.
23. + regulatory T cell function. Science 309: 1380-1384.
24. Collison, L. W., C. J. Workman, T. Kuo Timothy, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
25. Hayashi, T., L. Beck, C. Rossetto, C. Gong, O. Takikawa, K. Takabayashi, D. H. Broide, D. A. Carson, and E. Raz. 2004. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114: 270-279.
26. Quarcoo, D., S. Weixler, R. A. Joachim, P. Stock, T. Kallinich, B. Ahrens, and E. Hamelmann. 2004. Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin. Exp. Allergy 34: 1314-1320.
27. Sel, S., M. Wegmann, S. Sel, S. Bauer, H. Garn, G. Alber, and H. Renz. 2007. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J. Immunol. 178: 7805-7813.
28. Herrick, C. A., and K. Bottomly. 2003. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3: 405-412.
29. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
30. Ehlers, M., and J. V. Ravetch. 2007. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol. 28: 74-79.
31. Kool, M., T. Soullié, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882.
32. M. Goldman. 2007. Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin. Exp. Immunol. 147: 208-216.
33. Feng, X. M., X. L. Chen, N. Liu, Z. Chen, Y. L. Zhou, Z. B. Han, L. Zhang, and Z. C. Han. 2007. Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Hum. Immunol. 68: 965-972.
34. Pirhonen, J., J. Sirén, I. Julkunen, and S. Matikainen, S. 2007. IFN-α regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J. Leukocyte Biol. 82: 1185-1192.
35. Jankovic, D., and G. Trinchieri. 2007. IL-10 or not IL-10: that is the question. Nat. Immunol. 8: 1281-1283.
36. Stock, P., O. Akbari, G. Berry, G. J. Freeman, R. H. Dekruyff, and D. T. Umetsu. 2004. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 5: 1149-1156.
37. Benson, R. A., K. Adamson, M. Corsin-Jimenez, J. V. Marley, K. A. Wahl, J. R. Lamb, and S. E. Howie. 2005. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production. Eur. J. Immunol. 35: 859-869.
38. Crabtree, T. D., L. Jin, D. P. Raymond, S. J. Pelletier, C. W. Houlgrave, T. G. Gleason, T. L. Pruett, and R. G. Sawyer. 2001. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect. Immun. 69: 2123-2129.